Hims & Hers plunges as branded weight-loss drug pivot hits results
Hims & Hers plunges as branded weight-loss drug pivot hits results
Related Posts
Popular News
-
US inflation hits 3.3% as Bitcoin jumps above $72K after CPI
-
Private credit surge sparks split among US pension funds
-
Bitmine takes BMNR to NYSE with $4 billion buyback expansion
-
Fujairah and Khor Fakkan become UAE trade hubs amid Iran tensions
-
600,000 families have already applied for Trump accounts
Latest News
CVC appoints John Hourican as CFO
CVC Capital Partners has appointed John Hourican as chief financial officer, succeeding Fred Watt. Hourican, who previously filled the role...
Nvidia CEO Jensen Huang isn’t part of Trump’s China trip
U.S. President Donald Trump (L) listens as Nvidia CEO Jensen Huang speaks in the Cross Hall of the White House...
Alpenglow Upgrade Activates for Live Validator Testing
Solana’s Alpenglow upgrade entered community validator testing on May 11, with development firm Anza describing the activation as the largest...
This dot-com survivor says AI build-out is more like 1997 than 1999 — and still urges investors to hold more cash
The riveting gains for microchip stocks have many analysts drawing parallels to 1999, just ahead of the dot-com crash, when...
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.